Electronic health records: new opportunities for clinical research
Clinical research is on the threshold of a new era in which electronic health records ( EHR s)
are gaining an important novel supporting role. Whilst EHR s used for routine clinical care …
are gaining an important novel supporting role. Whilst EHR s used for routine clinical care …
Evidence-based strategies for implementing guidelines in obstetrics: a systematic review
OBJECTIVE: To estimate effective strategies for implementing clinical practice guidelines in
obstetric care and to identify specific barriers to behavior change and facilitators in obstetrics…
obstetric care and to identify specific barriers to behavior change and facilitators in obstetrics…
Cognitive-behavioral treatment for generalized anxiety disorder: Current status and future directions
MJ Dugas, N Koerner - Journal of Cognitive Psychotherapy, 2005 - search.proquest.com
… In this article and in earlier accounts of our GAD model and treatment (see Dugas & Ladouceur,
1998), we conceptualize worry as an approach-avoidance conflict. This formulation has …
1998), we conceptualize worry as an approach-avoidance conflict. This formulation has …
[HTML][HTML] Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
High-throughput DNA sequencing significantly contributed to diagnosis and prognostication
in patients with myelodysplastic syndromes (MDS). We determined the biological and …
in patients with myelodysplastic syndromes (MDS). We determined the biological and …
Experimental manipulation of intolerance of uncertainty: A study of a theoretical model of worry
R Ladouceur, P Gosselin, MJ Dugas - Behaviour research and therapy, 2000 - Elsevier
Intolerance of uncertainty has been identified as an important variable related to worry and
Generalized Anxiety Disorder (GAD) [Dugas, MJ, Gagnon, F., Ladouceur, R., & Freeston, MH (…
Generalized Anxiety Disorder (GAD) [Dugas, MJ, Gagnon, F., Ladouceur, R., & Freeston, MH (…
Why do people worry?
MH Freeston, J Rhéaume, H Letarte, MJ Dugas… - Personality and …, 1994 - Elsevier
… Studies on the French adaptation show excellent internal consistency, good test-retest
reliability, and preliminary evidence of validity (Dugas et ul., in press). The Beck Anxiety InventoF …
reliability, and preliminary evidence of validity (Dugas et ul., in press). The Beck Anxiety InventoF …
Generalized anxiety disorder: A preliminary test of a conceptual model
MJ Dugas, F Gagnon, R Ladouceur… - Behaviour research and …, 1998 - Elsevier
This study presents a preliminary test of a conceptual model of Generalized Anxiety Disorder
(GAD) which is theoretically driven and has clear clinical implications. The model's main …
(GAD) which is theoretically driven and has clear clinical implications. The model's main …
The intolerance of uncertainty scale: Psychometric properties of the English version
K Buhr, MJ Dugas - Behaviour research and therapy, 2002 - Elsevier
… who met the criteria for GAD by questionnaire (M=70.51, SD=12.56) scored significantly
higher on the IUS than those who met only the somatic criteria (M=57.12, SD=17.83), the latter …
higher on the IUS than those who met only the somatic criteria (M=57.12, SD=17.83), the latter …
Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine
…, A Doctor, A Davis, J Duff, MA Dugas… - Critical care …, 2009 - journals.lww.com
… Titration of therapy to CO 3.3–6.0 L/min/m 2 remains the goal in patients with persistent
catecholamine resistant shock in 2007 guidelines. Doppler echocardiography can also be used …
catecholamine resistant shock in 2007 guidelines. Doppler echocardiography can also be used …
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and …
S Schnittger, C Schoch, M Dugas… - Blood, The Journal …, 2002 - ashpublications.org
FLT3 length mutation (FLT3-LM) is a molecular marker potentially useful for the characterization
of acute myeloid leukemia (AML). To evaluate the distribution of FLT3-LM within biologic …
of acute myeloid leukemia (AML). To evaluate the distribution of FLT3-LM within biologic …